AFP and hepatocellular carcinoma: Moreover, glypican-3 (GCP3) is a heparan sulfate proteoglycan that can stimulate HCC growth through canonical Wnt/β-catenin-mediated signaling pathway, and its combination with AFP improves the sensitivity for HCC diagnosis up to 82% or 94%, depending on the HCC type [165].